Who is the first to receive the coronavirus vaccine? The answer is not so simple

Despite new coronavirus cases approaching the 19 million mark worldwide, scientists and the medical community around the world are working at breakneck speed to develop a vaccine for the new coronavirus. Therefore, as of now, there are more than 160 candidate vaccines to combat the new coronavirus at different stages of clinical trials, and 27 of them have already reached the crucial phase of human trials.

As the race to develop a vaccine fit for human use has intensified, several reports are hinting at the fact that a vaccine may be available later this year or early 2021. Currently, the University vaccine candidate Oxford’s ‘ChAdOx1 nCoV-19’ is touted as the leader in pinprick production for the new coronavirus, as it is currently in phase III (last stage) of human trials in the UK, Brazil and South Africa.

Serum Insitute of India will start human trials of the Oxford COVID vaccine

The Indian Whey Institute of India was also approved by the DGCI to carry out Phase II / III trials of the Oxford COVID-19 vaccine in India. It should be noted that the Pune-based Indian Whey Institute has partnered with the Swedish-British firm AstraZeneca to produce the COVID-19 vaccine for India and other low- and middle-income nations. To carry out Covishield phase II / II human trials (Oxford COVID vaccine), doses of approximately 1600 volunteers will be administered to the vaccine candidate.

Who will be first in line to receive the vaccine?

Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, is “cautiously optimistic” that a vaccine for the new coronavirus would be a “reality” by the end of this year or early 2021. Given that, there is much debate. how COVID-19 dosing will take place, as developed countries around the world are already signing billions of dollars in deals to secure their supply of coronavirus vaccines.

According to health experts from around the world, front-line workers, including healthcare workers and first responders, will be considered first in line to be vaccinated against the highly infectious contagious. However, things can get complicated after that, as there is no direct answer as to who should get the vaccine first.

Mass immunization is a complicated process

Not everyone is going to like the answer, “said Dr. Francis Collins, director of the United States National Institutes of Health.” There will be many people who feel they should have been at the top of the list, “he said. recently to one of the advisory groups the government requested to help decide.

However, Dr. Collins also underlined an important factor to consider when dosing begins: Priority should be given to areas where the pandemic has affected the most. In addition, he also noted that volunteers who received placebo doses during trials should also take precedence during the mass immunization process.

What do the CDC and the WHO have to say?

According to an agency report, the Center for Disease Control (CDC) has suggested vaccinating essential workers first, including health and national security workers. After that, people in the high-risk category, including people over 65 and those with chronic medical conditions, should be as follows. The general population would come later.

The World Health Organization defined a tentative “strategic allocation” plan for the coronavirus vaccine in June. According to the health agency, the world’s prioritized population included health system workers, adults over 65 and adults in a high-risk category. However, the question of the dosage of ethnic groups and low-income populations in society that are being hit hard by the coronavirus remains important.
read more

Back to top button